JPRN-UMIN000009365
Completed
Phase 1
Intervention trial for colorectal cancer prevention by endoscopic polypectomy in patients with familial adenomatous polyposis - Intervention trial for colorectal cancer prevention by endoscopic polypectomy in patients with FAP
Conditionsfamilial adenomatous polyposis
Overview
- Phase
- Phase 1
- Intervention
- Not specified
- Conditions
- familial adenomatous polyposis
- Sponsor
- AMED
- Enrollment
- 222
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •Patients who are considered by their attending physicians to be ineligible to participate in the study because they have a serious disease in other organs, or because they cannot discontinue antiplatelet drugs, or for other reasons. Patients who are receiving anticancer drugs. Patients with dense FAP in at least one\-third of the large intestine. Patients in whom strict follow\-up is difficult.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Phase 1
Intervention trial for colorectal cancer prevention by endoscopic polypectomy in patients with familial adenomatous polyposis -2Patients with familial adenomatous polyposisJPRN-UMIN000018742Kyoto Prefectural University of Medicine200
Active, not recruiting
Not Applicable
Phase I/II study of prevention of Colorectal Cancer CRC with Allopurinol in High-Risk Subjects - APACCHEMOPREVENTION OF COLORECTAL CANCERMedDRA version: 9.1Level: LLTClassification code 10048832Term: Colon adenomaEUCTR2006-001084-27-ITAZIENDA OSPEDALIERA OSPEDALI GALLIERA75
Active, not recruiting
Phase 2
Japan colorectal tumor prevention studycolorectal tumorJPRN-jRCTs061180079Takayama Tetsuji600
Completed
Phase 3
Japan colorectal tumor prevention study: clinical trial by low-dose aspiriPatients with colorectal tumor (adenoma, carcinoma in situ)JPRN-UMIN000018734Kyoto Prefectural University of Medicine7,000
Active, not recruiting
Phase 3
Japan colorectal tumor prevention study: clinical trial by low-dose aspirin (J-CAPP Study II)Patients with colorectal tumor (adenoma, carcinoma in situ)JPRN-jRCTs051180161Ishikawa Hideki4,500